Name of organisation
1) Department/Research groupLSHTM Pharmacoepidemiology Group
2) Organisation/affiliationLondon School of Hygiene & Tropical Medicine
Short Name in the inventoryLSHTM
Administrative Contact
Title Professor
Last name Evans
First name Stephen
Address line 1Department of Medical Statistics
Address line 2Keppel St
Address line 3
CityLondon
PostcodeWC1E 7HT
CountryUnited Kingdom
Phone number (incl. country code)442079272960
Alternative phone number447979600702
Fax number (incl. country code)
Scientific Contact
Title Professor
Last name Evans
First name Stephen
Address line 1Medical Statistics Unit
Address line 2Keppel St
Address line 3
CityLondon
PostcodeWC1E 7HT
CountryUnited Kingdom
Phone number (incl. country code)442079272960
Alternative phone number
Fax number (incl. country code)
Alternative Scientific Contact
Title Professor
Last name Smeeth
First name Liam
Address line 1Dept Non-Communicable Disease Epidemiology
Address line 2LSHTM
Address line 3Keppel St
CityLondon
PostcodeWC1E 7HT
CountryUnited Kingdom
Phone number (incl. country code)44 - 207 927 2296
Alternative phone number
Fax number (incl. country code)
2. Description
LSHTM as an Institution is Britain's national school of public health and a leading postgraduate institution worldwide. Part of the University of London, it is the largest institution of its kind in Europe with major depth & breadth of expertise encompassing many disciplines. It is about the 3rd highest-rated research institution in the UK.
There are ~4000 students from >100 countries in 22 taught masters courses locally (~650) or by distance learning (~2700), & doing PhDs (~400). There are ~1300 staff drawn from over 60 countries.
Research collaborations exist with >100 countries worldwide, utilizing our critical mass of multidisciplinary expertise which includes clinicians, epidemiologists, statisticians, social scientists, molecular biologists and immunologists. At any time >100 School staff are based overseas. We have a strong commitment to partnership with institutions in low and middle income countries to support the development of teaching and research capacity.
3. Category
University based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
Yes
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
Yes
Pharmacist
Yes
Yes
Geneticist/Pharmacogeneticist
Yes
Yes
IT specialist
Yes
Yes
Ethics expertise
Yes
Yes
Regulatory expertise
Yes
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Anaesthesia
Cardiovascular diseases
Congenital Malformations
Devices
Disorders of the central nervous system
Endocrine disorders
Eye disorders
Gastrointestinal tract
Geriatrics
Gynaecology
Immunological products and vaccines
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Osteoporosis
Paediatrics
Pregnancy
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Interventional Clinical Trial
Meta-Analysis
Self-controlled case series
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Less than 150
Between 150 and 1499
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
GPRD20
THIN25
Lifelink1
HES2
Mediplus1
11. Registries established by centre
None
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Other networks:
Network nameNationalInternationalLink to webpage